Malignant Hypertension: Ocular Manifestations [PDF]
The Scientific World Journal, 2006 Malignant hypertension may be the first manifestation of systemic hypertension. We report a clinical case of a Caucasian 41-year-old man with no previous history of blood hypertension seen at casualty because of blurred vision.
Silvia Muñoz +2 more
doaj +3 more sources
Efficacy of the novel MIGS implant Wistend compared to Kahook Dual Blade in the treatment of experimental ocular hypertension in rabbits [PDF]
Scientific ReportsTo evaluate and compare the efficacy of novel microinvasive glaucoma surgery (MIGS) device implants Wistend and Kahook Dual Blade (KDB) in an experimental ocular hypertension model. Twelve New Zealand white rabbits were randomized into four groups (blank,
Yu Zhang +10 more
doaj +2 more sources
Intraocular pressure modifications in patients with acute central/hemicentral retinal vein occlusions [PDF]
International Journal of Ophthalmology, 2021 Intraocular pressure (IOP) modifications in patients with acute central/hemicentral retinal vein occlusions (RVOs) consist in IOP reductions and increases.
Dan Calugaru, Mihai Calugaru
doaj +1 more source
Relationship between intraocular pressure and parameters of obesity in ocular hypertension [PDF]
International Journal of Ophthalmology, 2020 AIM: To evaluate the correlation between intraocular pressure (IOP) and various obesity-related health factors in patients with ocular hypertension in Korea. METHODS: A total of 40 850 subjects underwent age, sex, body weight, and height assessments and
Min Won Ahn +3 more
doaj +1 more source
Ocular hypertension and severe intraocular pressure elevation after posterior subtenon injection of triamcinolone acetonide for various diseases [PDF]
International Journal of Ophthalmology, 2020 AIM: To evaluate and compare the incidences of ocular hypertension and severe intraocular pressure (IOP) elevation after posterior subtenon injection of triamcinolone acetonide (PSTA) for various diseases.
Yun-Hsiang Yang +3 more
doaj +1 more source
eLife, 2021 Glucocorticoids are widely used as an ophthalmic medication. A common, sight-threatening adverse event of glucocorticoid usage is ocular hypertension, caused by dysfunction of the conventional outflow pathway.
Guorong Li +16 more
doaj +1 more source
Progression from ocular hypertension to visual field loss in the English hospital eye service [PDF]
, 2020 Background There are more than one million National Health Service visits in England and Wales each year for patients with glaucoma or ocular hypertension (OHT).
Azuara-Blanco, A. +5 more
core +2 more sources
Relationship between blood pressure and intraocular pressure in the JPHC-NEXT eye study
Scientific Reports, 2022 Although a positive link between hypertension and intraocular pressure (IOP) has been suggested, the individual effects of systolic and diastolic blood pressure (SBP and DBP, respectively) on IOP remain unclear, particularly among Japanese populations ...
Tomoyo Yasukawa +11 more
doaj +1 more source
Intraocular Pressure Fluctuation: Is It Important? [PDF]
, 2018 Elevated intraocular pressure (IOP) is a major risk factor for the development and progression of glaucoma. Previous prospective, randomized, long-term studies have demonstrated the strength of IOP reduction in slowing the progression of disease.
Caprioli, Joseph, Kim, Ji Hyun
core +5 more sources